---
title: "Cathay Biotech: Net profit in the first half of the year was 309 million yuan, a year-on-year increase of 24.74%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253236238.md"
description: "Cathay Biotech released its 2025 semi-annual report, achieving operating revenue of 1.671 billion yuan in the first half of the year, a year-on-year increase of 15.68%; net profit attributable to the parent company was 309 million yuan, a year-on-year increase of 24.74%. During the reporting period, the company's series of long-chain dicarboxylic acids continued to ramp up production, with sales revenue and gross profit from sales continuously rising, driving year-on-year growth in operating revenue, total profit, and net profit"
datetime: "2025-08-15T13:36:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253236238.md)
  - [en](https://longbridge.com/en/news/253236238.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253236238.md)
generator: "portal-rs"
---

# Cathay Biotech: Net profit in the first half of the year was 309 million yuan, a year-on-year increase of 24.74%

Cathay Biotech released its semi-annual report for 2025, achieving operating revenue of 1.671 billion yuan in the first half of the year, a year-on-year increase of 15.68%; net profit attributable to the parent company was 309 million yuan, a year-on-year increase of 24.74%. During the reporting period, the company's series of long-chain dicarboxylic acids continued to ramp up production, with sales revenue and gross profit from sales continuously rising, driving growth in operating revenue, total profit, and net profit compared to the same period last year

### Related Stocks

- [688065.CN](https://longbridge.com/en/quote/688065.CN.md)

## Related News & Research

- [Golf-PGA Tour overhauls post-season, moving to match play format in 2028](https://longbridge.com/en/news/296930417.md)
- [Lenzing shareholders approve EUR 300 million capital increase at extraordinary meeting](https://longbridge.com/en/news/296902548.md)
- [08:02 ETFour Kantor & Kantor, LLP Attorneys Recognized in the 2027 Edition of The Best Lawyers in America ®](https://longbridge.com/en/news/297041639.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [NFL-NFL, NFLPA tighten discipline for repeat player-safety violations](https://longbridge.com/en/news/297094204.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**